Global Biogeneric Drugs Market Research Report 2023

Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.

The global Biogeneric Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company’s return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.

This report aims to provide a comprehensive presentation of the global market for Biogeneric Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biogeneric Drugs.

The Biogeneric Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biogeneric Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biogeneric Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Biogeneric Drugs

1.2 Biogeneric Drugs Segment by Type

1.2.1 Global Biogeneric Drugs Market Value Comparison by Type (2023-2029)

1.2.2 Insulins

1.2.3 Growth Hormones

1.2.4 Monoclonal Antibodies

1.2.5 Others

1.3 Biogeneric Drugs Segment by Application

1.3.1 Global Biogeneric Drugs Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Research Centers

1.4 Global Biogeneric Drugs Market Size Estimates and Forecasts

1.4.1 Global Biogeneric Drugs Revenue 2018-2029

1.4.2 Global Biogeneric Drugs Sales 2018-2029

1.4.3 Global Biogeneric Drugs Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Biogeneric Drugs Sales Market Share by Manufacturers (2018-2023)

2.2 Global Biogeneric Drugs Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Biogeneric Drugs Average Price by Manufacturers (2018-2023)

2.4 Global Biogeneric Drugs Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Biogeneric Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Biogeneric Drugs, Product Type & Application

2.7 Biogeneric Drugs Market Competitive Situation and Trends

2.7.1 Biogeneric Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Biogeneric Drugs Players Market Share by Revenue

2.7.3 Global Biogeneric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Biogeneric Drugs Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Biogeneric Drugs Global Biogeneric Drugs Sales by Region: 2018-2029

3.2.1 Global Biogeneric Drugs Sales by Region: 2018-2023

3.2.2 Global Biogeneric Drugs Sales by Region: 2024-2029

3.3 Global Biogeneric Drugs Global Biogeneric Drugs Revenue by Region: 2018-2029

3.3.1 Global Biogeneric Drugs Revenue by Region: 2018-2023

3.3.2 Global Biogeneric Drugs Revenue by Region: 2024-2029

3.4 North America Biogeneric Drugs Market Facts & Figures by Country

3.4.1 North America Biogeneric Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Biogeneric Drugs Sales by Country (2018-2029)

3.4.3 North America Biogeneric Drugs Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Biogeneric Drugs Market Facts & Figures by Country

3.5.1 Europe Biogeneric Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Biogeneric Drugs Sales by Country (2018-2029)

3.5.3 Europe Biogeneric Drugs Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Biogeneric Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Biogeneric Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Biogeneric Drugs Sales by Country (2018-2029)

3.6.3 Asia Pacific Biogeneric Drugs Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Biogeneric Drugs Market Facts & Figures by Country

3.7.1 Latin America Biogeneric Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Biogeneric Drugs Sales by Country (2018-2029)

3.7.3 Latin America Biogeneric Drugs Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Biogeneric Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Biogeneric Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Biogeneric Drugs Sales by Country (2018-2029)

3.8.3 Middle East and Africa Biogeneric Drugs Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Biogeneric Drugs Sales by Type (2018-2029)

4.1.1 Global Biogeneric Drugs Sales by Type (2018-2023)

4.1.2 Global Biogeneric Drugs Sales by Type (2024-2029)

4.1.3 Global Biogeneric Drugs Sales Market Share by Type (2018-2029)

4.2 Global Biogeneric Drugs Revenue by Type (2018-2029)

4.2.1 Global Biogeneric Drugs Revenue by Type (2018-2023)

4.2.2 Global Biogeneric Drugs Revenue by Type (2024-2029)

4.2.3 Global Biogeneric Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Biogeneric Drugs Price by Type (2018-2029)

5.1 Global Biogeneric Drugs Sales by Application (2018-2029)

5.1.1 Global Biogeneric Drugs Sales by Application (2018-2023)

5.1.2 Global Biogeneric Drugs Sales by Application (2024-2029)

5.1.3 Global Biogeneric Drugs Sales Market Share by Application (2018-2029)

5.2 Global Biogeneric Drugs Revenue by Application (2018-2029)

5.2.1 Global Biogeneric Drugs Revenue by Application (2018-2023)

5.2.2 Global Biogeneric Drugs Revenue by Application (2024-2029)

5.2.3 Global Biogeneric Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Biogeneric Drugs Price by Application (2018-2029)

6.1 Sandoz International

6.1.1 Sandoz International Corporation Information

6.1.2 Sandoz International Description and Business Overview

6.1.3 Sandoz International Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Sandoz International Biogeneric Drugs Product Portfolio

6.1.5 Sandoz International Recent Developments/Updates

6.2 Teva pharmaceutical industries

6.2.1 Teva pharmaceutical industries Corporation Information

6.2.2 Teva pharmaceutical industries Description and Business Overview

6.2.3 Teva pharmaceutical industries Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Teva pharmaceutical industries Biogeneric Drugs Product Portfolio

6.2.5 Teva pharmaceutical industries Recent Developments/Updates

6.3 Mylan

6.3.1 Mylan Corporation Information

6.3.2 Mylan Description and Business Overview

6.3.3 Mylan Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Mylan Biogeneric Drugs Product Portfolio

6.3.5 Mylan Recent Developments/Updates

6.4 3SBio

6.4.1 3SBio Corporation Information

6.4.2 3SBio Description and Business Overview

6.4.3 3SBio Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 3SBio Biogeneric Drugs Product Portfolio

6.4.5 3SBio Recent Developments/Updates

6.5 Shanghai Fosun Pharmaceutical

6.5.1 Shanghai Fosun Pharmaceutical Corporation Information

6.5.2 Shanghai Fosun Pharmaceutical Description and Business Overview

6.5.3 Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Shanghai Fosun Pharmaceutical Biogeneric Drugs Product Portfolio

6.5.5 Shanghai Fosun Pharmaceutical Recent Developments/Updates

6.6 Tonghua Dongbao Pharmaceutical

6.6.1 Tonghua Dongbao Pharmaceutical Corporation Information

6.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview

6.6.3 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Product Portfolio

6.6.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates

6.7 Biocon

6.6.1 Biocon Corporation Information

6.6.2 Biocon Description and Business Overview

6.6.3 Biocon Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Biocon Biogeneric Drugs Product Portfolio

6.7.5 Biocon Recent Developments/Updates

6.8 Reliance life sciences

6.8.1 Reliance life sciences Corporation Information

6.8.2 Reliance life sciences Description and Business Overview

6.8.3 Reliance life sciences Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Reliance life sciences Biogeneric Drugs Product Portfolio

6.8.5 Reliance life sciences Recent Developments/Updates

6.9 Probiomed

6.9.1 Probiomed Corporation Information

6.9.2 Probiomed Description and Business Overview

6.9.3 Probiomed Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Probiomed Biogeneric Drugs Product Portfolio

6.9.5 Probiomed Recent Developments/Updates

6.10 Biosidus

6.10.1 Biosidus Corporation Information

6.10.2 Biosidus Description and Business Overview

6.10.3 Biosidus Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Biosidus Biogeneric Drugs Product Portfolio

6.10.5 Biosidus Recent Developments/Updates

6.11 AMEGA Biotech

6.11.1 AMEGA Biotech Corporation Information

6.11.2 AMEGA Biotech Biogeneric Drugs Description and Business Overview

6.11.3 AMEGA Biotech Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.11.4 AMEGA Biotech Biogeneric Drugs Product Portfolio

6.11.5 AMEGA Biotech Recent Developments/Updates

6.12 Celltrion

6.12.1 Celltrion Corporation Information

6.12.2 Celltrion Biogeneric Drugs Description and Business Overview

6.12.3 Celltrion Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Celltrion Biogeneric Drugs Product Portfolio

6.12.5 Celltrion Recent Developments/Updates

6.13 LG life Science

6.13.1 LG life Science Corporation Information

6.13.2 LG life Science Biogeneric Drugs Description and Business Overview

6.13.3 LG life Science Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.13.4 LG life Science Biogeneric Drugs Product Portfolio

6.13.5 LG life Science Recent Developments/Updates

6.14 Dong-A Pharmaceutical

6.14.1 Dong-A Pharmaceutical Corporation Information

6.14.2 Dong-A Pharmaceutical Biogeneric Drugs Description and Business Overview

6.14.3 Dong-A Pharmaceutical Biogeneric Drugs Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Dong-A Pharmaceutical Biogeneric Drugs Product Portfolio

6.14.5 Dong-A Pharmaceutical Recent Developments/Updates

7.1 Biogeneric Drugs Industry Chain Analysis

7.2 Biogeneric Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Biogeneric Drugs Production Mode & Process

7.4 Biogeneric Drugs Sales and Marketing

7.4.1 Biogeneric Drugs Sales Channels

7.4.2 Biogeneric Drugs Distributors

7.5 Biogeneric Drugs Customers

8.1 Biogeneric Drugs Industry Trends

8.2 Biogeneric Drugs Market Drivers

8.3 Biogeneric Drugs Market Challenges

8.4 Biogeneric Drugs Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Biogeneric Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Biogeneric Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Biogeneric Drugs Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Biogeneric Drugs Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Biogeneric Drugs Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Biogeneric Drugs Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Biogeneric Drugs Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Biogeneric Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Biogeneric Drugs, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Biogeneric Drugs, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Biogeneric Drugs, Product Type & Application

    Table 12. Global Key Manufacturers of Biogeneric Drugs, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Biogeneric Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biogeneric Drugs as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Biogeneric Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Biogeneric Drugs Sales by Region (2018-2023) & (K Units)

    Table 18. Global Biogeneric Drugs Sales Market Share by Region (2018-2023)

    Table 19. Global Biogeneric Drugs Sales by Region (2024-2029) & (K Units)

    Table 20. Global Biogeneric Drugs Sales Market Share by Region (2024-2029)

    Table 21. Global Biogeneric Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Biogeneric Drugs Revenue Market Share by Region (2018-2023)

    Table 23. Global Biogeneric Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Biogeneric Drugs Revenue Market Share by Region (2024-2029)

    Table 25. North America Biogeneric Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Biogeneric Drugs Sales by Country (2018-2023) & (K Units)

    Table 27. North America Biogeneric Drugs Sales by Country (2024-2029) & (K Units)

    Table 28. North America Biogeneric Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Biogeneric Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Biogeneric Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Biogeneric Drugs Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Biogeneric Drugs Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Biogeneric Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Biogeneric Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Biogeneric Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Biogeneric Drugs Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Biogeneric Drugs Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Biogeneric Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Biogeneric Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Biogeneric Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Biogeneric Drugs Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Biogeneric Drugs Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Biogeneric Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Biogeneric Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Biogeneric Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Biogeneric Drugs Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Biogeneric Drugs Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Biogeneric Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Biogeneric Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Biogeneric Drugs Sales (K Units) by Type (2018-2023)

    Table 51. Global Biogeneric Drugs Sales (K Units) by Type (2024-2029)

    Table 52. Global Biogeneric Drugs Sales Market Share by Type (2018-2023)

    Table 53. Global Biogeneric Drugs Sales Market Share by Type (2024-2029)

    Table 54. Global Biogeneric Drugs Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Biogeneric Drugs Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Biogeneric Drugs Revenue Market Share by Type (2018-2023)

    Table 57. Global Biogeneric Drugs Revenue Market Share by Type (2024-2029)

    Table 58. Global Biogeneric Drugs Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Biogeneric Drugs Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Biogeneric Drugs Sales (K Units) by Application (2018-2023)

    Table 61. Global Biogeneric Drugs Sales (K Units) by Application (2024-2029)

    Table 62. Global Biogeneric Drugs Sales Market Share by Application (2018-2023)

    Table 63. Global Biogeneric Drugs Sales Market Share by Application (2024-2029)

    Table 64. Global Biogeneric Drugs Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Biogeneric Drugs Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Biogeneric Drugs Revenue Market Share by Application (2018-2023)

    Table 67. Global Biogeneric Drugs Revenue Market Share by Application (2024-2029)

    Table 68. Global Biogeneric Drugs Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Biogeneric Drugs Price (USD/Unit) by Application (2024-2029)

    Table 70. Sandoz International Corporation Information

    Table 71. Sandoz International Description and Business Overview

    Table 72. Sandoz International Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Sandoz International Biogeneric Drugs Product

    Table 74. Sandoz International Recent Developments/Updates

    Table 75. Teva pharmaceutical industries Corporation Information

    Table 76. Teva pharmaceutical industries Description and Business Overview

    Table 77. Teva pharmaceutical industries Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Teva pharmaceutical industries Biogeneric Drugs Product

    Table 79. Teva pharmaceutical industries Recent Developments/Updates

    Table 80. Mylan Corporation Information

    Table 81. Mylan Description and Business Overview

    Table 82. Mylan Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Mylan Biogeneric Drugs Product

    Table 84. Mylan Recent Developments/Updates

    Table 85. 3SBio Corporation Information

    Table 86. 3SBio Description and Business Overview

    Table 87. 3SBio Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. 3SBio Biogeneric Drugs Product

    Table 89. 3SBio Recent Developments/Updates

    Table 90. Shanghai Fosun Pharmaceutical Corporation Information

    Table 91. Shanghai Fosun Pharmaceutical Description and Business Overview

    Table 92. Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Shanghai Fosun Pharmaceutical Biogeneric Drugs Product

    Table 94. Shanghai Fosun Pharmaceutical Recent Developments/Updates

    Table 95. Tonghua Dongbao Pharmaceutical Corporation Information

    Table 96. Tonghua Dongbao Pharmaceutical Description and Business Overview

    Table 97. Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Tonghua Dongbao Pharmaceutical Biogeneric Drugs Product

    Table 99. Tonghua Dongbao Pharmaceutical Recent Developments/Updates

    Table 100. Biocon Corporation Information

    Table 101. Biocon Description and Business Overview

    Table 102. Biocon Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Biocon Biogeneric Drugs Product

    Table 104. Biocon Recent Developments/Updates

    Table 105. Reliance life sciences Corporation Information

    Table 106. Reliance life sciences Description and Business Overview

    Table 107. Reliance life sciences Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Reliance life sciences Biogeneric Drugs Product

    Table 109. Reliance life sciences Recent Developments/Updates

    Table 110. Probiomed Corporation Information

    Table 111. Probiomed Description and Business Overview

    Table 112. Probiomed Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Probiomed Biogeneric Drugs Product

    Table 114. Probiomed Recent Developments/Updates

    Table 115. Biosidus Corporation Information

    Table 116. Biosidus Description and Business Overview

    Table 117. Biosidus Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Biosidus Biogeneric Drugs Product

    Table 119. Biosidus Recent Developments/Updates

    Table 120. AMEGA Biotech Corporation Information

    Table 121. AMEGA Biotech Description and Business Overview

    Table 122. AMEGA Biotech Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. AMEGA Biotech Biogeneric Drugs Product

    Table 124. AMEGA Biotech Recent Developments/Updates

    Table 125. Celltrion Corporation Information

    Table 126. Celltrion Description and Business Overview

    Table 127. Celltrion Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Celltrion Biogeneric Drugs Product

    Table 129. Celltrion Recent Developments/Updates

    Table 130. LG life Science Corporation Information

    Table 131. LG life Science Description and Business Overview

    Table 132. LG life Science Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. LG life Science Biogeneric Drugs Product

    Table 134. LG life Science Recent Developments/Updates

    Table 135. Dong-A Pharmaceutical Corporation Information

    Table 136. Dong-A Pharmaceutical Description and Business Overview

    Table 137. Dong-A Pharmaceutical Biogeneric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Dong-A Pharmaceutical Biogeneric Drugs Product

    Table 139. Dong-A Pharmaceutical Recent Developments/Updates

    Table 140. Key Raw Materials Lists

    Table 141. Raw Materials Key Suppliers Lists

    Table 142. Biogeneric Drugs Distributors List

    Table 143. Biogeneric Drugs Customers List

    Table 144. Biogeneric Drugs Market Trends

    Table 145. Biogeneric Drugs Market Drivers

    Table 146. Biogeneric Drugs Market Challenges

    Table 147. Biogeneric Drugs Market Restraints

    Table 148. Research Programs/Design for This Report

    Table 149. Key Data Information from Secondary Sources

    Table 150. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Biogeneric Drugs

    Figure 2. Global Biogeneric Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Biogeneric Drugs Market Share by Type in 2022 & 2029

    Figure 4. Insulins Product Picture

    Figure 5. Growth Hormones Product Picture

    Figure 6. Monoclonal Antibodies Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Biogeneric Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Biogeneric Drugs Market Share by Application in 2022 & 2029

    Figure 10. Hospital

    Figure 11. Clinics

    Figure 12. Research Centers

    Figure 13. Global Biogeneric Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Biogeneric Drugs Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Biogeneric Drugs Sales (2018-2029) & (K Units)

    Figure 16. Global Biogeneric Drugs Average Price (USD/Unit) & (2018-2029)

    Figure 17. Biogeneric Drugs Report Years Considered

    Figure 18. Biogeneric Drugs Sales Share by Manufacturers in 2022

    Figure 19. Global Biogeneric Drugs Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Biogeneric Drugs Players: Market Share by Revenue in 2022

    Figure 21. Biogeneric Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Biogeneric Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Biogeneric Drugs Sales Market Share by Country (2018-2029)

    Figure 24. North America Biogeneric Drugs Revenue Market Share by Country (2018-2029)

    Figure 25. U.S. Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Biogeneric Drugs Sales Market Share by Country (2018-2029)

    Figure 28. Europe Biogeneric Drugs Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Biogeneric Drugs Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Biogeneric Drugs Revenue Market Share by Region (2018-2029)

    Figure 36. China Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Taiwan Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Indonesia Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Thailand Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Malaysia Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Philippines Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Latin America Biogeneric Drugs Sales Market Share by Country (2018-2029)

    Figure 47. Latin America Biogeneric Drugs Revenue Market Share by Country (2018-2029)

    Figure 48. Mexico Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Brazil Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Argentina Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Middle East & Africa Biogeneric Drugs Sales Market Share by Country (2018-2029)

    Figure 52. Middle East & Africa Biogeneric Drugs Revenue Market Share by Country (2018-2029)

    Figure 53. Turkey Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Saudi Arabia Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. U.A.E Biogeneric Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Global Sales Market Share of Biogeneric Drugs by Type (2018-2029)

    Figure 57. Global Revenue Market Share of Biogeneric Drugs by Type (2018-2029)

    Figure 58. Global Biogeneric Drugs Price (USD/Unit) by Type (2018-2029)

    Figure 59. Global Sales Market Share of Biogeneric Drugs by Application (2018-2029)

    Figure 60. Global Revenue Market Share of Biogeneric Drugs by Application (2018-2029)

    Figure 61. Global Biogeneric Drugs Price (USD/Unit) by Application (2018-2029)

    Figure 62. Biogeneric Drugs Value Chain

    Figure 63. Biogeneric Drugs Production Process

    Figure 64. Channels of Distribution (Direct Vs Distribution)

    Figure 65. Distributors Profiles

    Figure 66. Bottom-up and Top-down Approaches for This Report

    Figure 67. Data Triangulation

    Figure 68. Key Executives Interviewed